Flavonols and cardiovascular disease

Molecular Aspects of Medicine

Volumn 31, Issue 6, 2010, Pages 478-494

  Perez Vizcaino, Francisco ^a   Duarte, Juan ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Endothelium; Hypertension; Insulin resistance; Ischaemic heart disease; Quercetin; Stroke

Indexed keywords

ACARBOSE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FLAVONOID; FLAVONOL DERIVATIVE; GLITAZONE DERIVATIVE; GLUCURONIDE; INCRETIN; KAEMPFEROL; METFORMIN; NITRIC OXIDE SYNTHASE; QUERCETIN; SULFONYLUREA DERIVATIVE;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIET THERAPY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; THERAPY EFFECT; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FLAVONOLS; HUMANS; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; QUERCETIN;

EID: 78649635059     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2010.09.002     Document Type: Review

References (159)

1. Ahn J., Lee H., Kim S., Park J., Ha T. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 2008, 373:545-549.
2. Ahn M.R., Kunimasa K., Kumazawa S., Nakayama T., Kaji K., Uto Y., Hori H., Nagasawa H., Ohta T. Correlation between antiangiogenic activity and antioxidant activity of various components from propolis. Mol. Nutr. Food Res. 2009, 53:643-651.
3. Ajay M., Achike F.I., Mustafa A.M., Mustafa M.R. Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract. 2006, 73:1-7.
4. Ajay M., Gilani A.U., Mustafa M.R. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci. 2003, 74:603-612.
5. Andriambeloson E., Magnier C., Haan-Archipoff G., Lobstein A., Anton R., Beretz A., Stoclet J.C., Andriantsitohaina R. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J. Nutr. 1998, 128:2324-2333.
6. Annapurna A., Reddy C.S., Akondi R.B., Rao S.R. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. J. Pharm. Pharmacol. 2009, 61:1365-1374.
7. Aoi W., Niisato N., Miyazaki H., Marunaka Y. Flavonoid-induced reduction of ENaC expression in the kidney of Dahl salt-sensitive hypertensive rat. Biochem. Biophys. Res. Commun. 2004, 315:892-896.
8. Auger C., Teissedre P.L., Gerain P., Lequeux N., Bornet A., Serisier S., Besancon P., Caporiccio B., Cristol J.P., Rouanet J.M. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem. 2005, 53:2015-2021.
9. Aviram M., Rosenblat M., Billecke S., Erogul J., Sorenson R., Bisgaier C.L., Newton R.S., La Du B. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 1999, 26:892-904.
10. Barker D.J. In utero programming of chronic disease. Clin. Sci. (Lond.) 1998, 95:115-128.
11. Bast A., Wolf G., Oberbaumer I., Walther R. Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 2002, 45:867-876.
12. Belinha I., Amorim M.A., Rodrigues P., de Freitas V., Moradas-Ferreira P., Mateus N., Costa V. Quercetin increases oxidative stress resistance and longevity in Saccharomyces cerevisiae. J. Agric. Food Chem. 2007, 55:2446-2451.
13. Benito S., Lopez D., Saiz M.P., Buxaderas S., Sanchez J., Puig-Parellada P., Mitjavila M.T. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br. J. Pharmacol. 2002, 135:910-916.
14. Beretz A., Cazenave J.P., Anton R. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships. Agents Actions 1982, 12:382-387.
15. Bergeron R., Russell R.R., Young L.H., Ren J.M., Marcucci M., Lee A., Shulman G.I. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am. J. Physiol. 1999, 276:E938-E944.
16. Bieger J., Cermak R., Blank R., de Boer V.C., Hollman P.C., Kamphues J., Wolffram S. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J. Nutr. 2008, 138:1417-1420.
17. Boesch-Saadatmandi C., Loboda A., Wagner A.E., Stachurska A., Jozkowicz A., Dulak J., Doring F., Wolffram S., Rimbach G. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J. Nutr. Biochem. 2010, 10.1016/j.jnutbio.2010.02.008.
18. Brookes P.S., Digerness S.B., Parks D.A., Darley-Usmar V. Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin. Free Radic. Biol. Med. 2002, 32:1220-1228.
19. Brunner F., Bras-Silva C., Cerdeira A.S., Leite-Moreira A.F. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol. Ther. 2006, 111:508-531.
20. Buckley A.J., Keseru B., Briody J., Thompson M., Ozanne S.E., Thompson C.H. Altered body composition and metabolism in the male offspring of high fat-fed rats. Metabolism 2005, 54:500-507.
21. Busse W.W., Kopp D.E., Middleton E. Flavonoid modulation of human neutrophil function. J. Allergy Clin. Immunol. 1984, 73:801-809.
22. Carlstrom J., Symons J.D., Wu T.C., Bruno R.S., Litwin S.E., Jalili T. A quercetin supplemented diet does not prevent cardiovascular complications in spontaneously hypertensive rats. J. Nutr. 2007, 137:628-633.
23. 2. Role in vasodilatation. Cardiovasc. Res. 2007, 73:424-431.
24. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., Howitz K.T., Gorospe M., de Cabo R., Sinclair D.A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305:390-392.
25. Comalada M., Ballester I., Bailon E., Sierra S., Xaus J., Galvez J., de Medina F.S., Zarzuelo A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem. Pharmacol. 2006, 72:1010-1021.
26. Conquer J.A., Maiani G., Azzini E., Raguzzini A., Holub B.J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr. 1998, 128:593-597.
27. Corriu C., Feletou M., Canet E., Vanhoutte P.M. Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br. J. Pharmacol. 1996, 119:959-964.
28. Coskun O., Kanter M., Korkmaz A., Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol. Res. 2005, 51:117-123.
29. Cho J.Y., Kim I.S., Jang Y.H., Kim A.R., Lee S.R. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci. Lett. 2006, 404:330-335.
30. Dajas F., Rivera F., Blasina F., Arredondo F., Echeverry C., Lafon L., Morquio A., Heizen H. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox. Res. 2003, 5:425-432.
31. Dauchet L., Amouyel P., Dallongeville J. Fruits, vegetables and coronary heart disease. Nat. Rev. Cardiol. 2009, 6:599-608.
32. Davalos A., Castilla P., Gomez-Cordoves C., Bartolome B. Quercetin is bioavailable from a single ingestion of grape juice. Int. J. Food Sci. Nutr. 2006, 57:391-398.
33. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J. Nutr. 2005, 135:2299-2304.
34. Duarte J., Jimenez R., O'Valle F., Galisteo M., Perez-Palencia R., Vargas F., Perez-Vizcaino F., Zarzuelo A., Tamargo J. Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J. Hypertens. 2002, 20:1843-1854.
35. Duarte J., Jimenez R., Villar I.C., Perez-Vizcaino F., Jimenez J., Tamargo J. Vasorelaxant effects of the bioflavonoid chrysin in isolated rat aorta. Planta Med. 2001, 67:567-569.
36. Duarte J., Perez-Palencia R., Vargas F., Ocete M.A., Perez-Vizcaino F., Zarzuelo A., Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 2001, 133:117-124.
37. Duarte J., Perez-Vizcaino F., Zarzuelo A., Jimenez J., Tamargo J. Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur. J. Pharmacol. 1993, 239:1-7.
38. Duarte J., Perez Vizcaino F., Utrilla P., Jimenez J., Tamargo J., Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol. 1993, 24:857-862.
39. Echeverry C., Arredondo F., Abin-Carriquiry J.A., Midiwo J.O., Ochieng C., Kerubo L., Dajas F. Pretreatment with natural flavones and neuronal cell survival after oxidative stress: a structure-activity relationship study. J. Agric. Food Chem. 2010, 58:2111-2115.
40. Edwards R.L., Lyon T., Litwin S.E., Rabovsky A., Symons J.D., Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 2007, 137:2405-2411.
41. Egert S., Boesch-Saadatmandi C., Wolffram S., Rimbach G., Muller M.J. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J. Nutr. 2010, 140:278-284.
42. Eid H.M., Martineau L.C., Saleem A., Muhammad A., Vallerand D., Benhaddou-Andaloussi A., Nistor L., Afshar A., Arnason J.T., Haddad P.S. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol. Nutr. Food Res. 2010, 54:991-1003.
43. Fang X.K., Gao J., Zhu D.N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci. 2008, 82:615-622.
44. Feletou M., Vanhoutte P.M. EDHF: an update. Clin. Sci. (Lond.) 2009, 117:139-155.
45. Fitzpatrick D.F., Hirschfield S.L., Coffey R.G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am. J. Physiol. 1993, 265:H774-778.
46. Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341:454-457.
47. Fryer L.G., Foufelle F., Barnes K., Baldwin S.A., Woods A., Carling D. Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem. J. 2002, 363:167-174.
48. Galisteo M., Garcia-Saura M.F., Jimenez R., Villar I.C., Wangensteen R., Zarzuelo A., Vargas F., Duarte J. Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil. Planta Med. 2004, 70:334-341.
49. Garcia-Saura M.F., Galisteo M., Villar I.C., Bermejo A., Zarzuelo A., Vargas F., Duarte J. Effects of chronic quercetin treatment in experimental renovascular hypertension. Mol. Cell Biochem. 2005, 270:147-155.
50. Gong M., Garige M., Varatharajalu R., Marmillot P., Gottipatti C., Leckey L.C., Lakshman R.M. Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation. Biochem. Biophys. Res. Commun. 2009, 379:1001-1004.
51. Granado-Serrano A.B., Martin M.A., Bravo L., Goya L., Ramos S. Quercetin modulates NF-kappa B and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr. Cancer 2010, 62:390-401.
52. Gryglewski R.J., Korbut R., Robak J., Swies J. On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol. 1987, 36:317-322.
53. Hayek T., Fuhrman B., Vaya J., Rosenblat M., Belinky P., Coleman R., Elis A., Aviram M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2744-2752.
54. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342:1007-1011.
55. Hollman P.C., de Vries J.H., van Leeuwen S.D., Mengelers M.J., Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62:1276-1282.
56. Hollman P.C., Geelen A., Kromhout D. Dietary flavonol intake may lower stroke risk in men and women. J. Nutr. 2010, 140:600-604.
57. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
58. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
59. Huang Y.T., Hwang J.J., Lee P.P., Ke F.C., Huang J.H., Huang C.J., Kandaswami C., Middleton E., Lee M.T. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol. 1999, 128:999-1010.
60. Huxley R.R., Neil H.A. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 2003, 57:904-908.
61. Ibarra M., Moreno L., Vera R., Cogolludo A., Duarte J., Tamargo J., Perez-Vizcaino F. Effects of the flavonoid quercetin and its methylated metabolite isorhamnetin in isolated arteries from spontaneously hypertensive rats. Planta Med. 2003, 69:995-1000.
62. Ibarra M., Perez-Vizcaino F., Cogolludo A., Duarte J., Zaragoza-Arnaez F., Lopez-Lopez J.G., Tamargo J. Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atria. Planta Med. 2002, 68:307-310.
63. Igura K., Ohta T., Kuroda Y., Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 2001, 171:11-16.
64. Ishiki M., Klip A. Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 2005, 146:5071-5078.
65. Jackson S.J., Venema R.C. Quercetin inhibits eNOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells. J. Nutr. 2006, 136:1178-1184.
66. Jalili T., Carlstrom J., Kim S., Freeman D., Jin H., Wu T.C., Litwin S.E., David Symons J. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J. Cardiovasc. Pharmacol. 2006, 47:531-541.
67. Janssen K., Mensink R.P., Cox F.J., Harryvan J.L., Hovenier R., Hollman P.C., Katan M.B. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am. J. Clin. Nutr. 1998, 67:255-262.
68. Jimenez R., Andriambeloson E., Duarte J., Andriantsitohaina R., Jimenez J., Perez-Vizcaino F., Zarzuelo A., Tamargo J. Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. Br. J. Pharmacol. 1999, 127:1539-1544.
69. Joint-Committee-Nomenclature-ASBC-AIN Term "vitamin P" recommended to be discontinued. Science 1950, 112:268.
70. Jurkovicova D., Kopacek J., Stefanik P., Kubovcakova L., Zahradnikova A., Zahradnikova A., Pastorekova S., Krizanova O. Hypoxia modulates gene expression of IP3 receptors in rodent cerebellum. Pflugers Arch. 2007, 454:415-425.
71. Kamada C., da Silva E.L., Ohnishi-Kameyama M., Moon J.H., Terao J. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic. Res. 2005, 39:185-194.
72. Kao T.K., Ou Y.C., Raung S.L., Lai C.Y., Liao S.L., Chen C.J. Inhibition of nitric oxide production by quercetin in endotoxin/cytokine-stimulated microglia. Life Sci. 2010, 86:315-321.
73. Kawai Y., Nishikawa T., Shiba Y., Saito S., Murota K., Shibata N., Kobayashi M., Kanayama M., Uchida K., Terao J. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J. Biol. Chem. 2008, 283:9424-9434.
74. Keli S.O., Hertog M.G., Feskens E.J., Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch. Intern. Med. 1996, 156:637-642.
75. Kellett G.L., Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 2005, 54:3056-3062.
76. Khan N.Q., Lees D.M., Douthwaite J.A., Carrier M.J., Corder R. Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin. Sci. (Lond.) 2002, 103(Suppl. 48):72S-75S.
77. Khoo N.K., White C.R., Pozzo-Miller L., Zhou F., Constance C., Inoue T., Patel R.P., Parks D.A. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic. Biol. Med. 2010, 49:339-347.
78. Kim J.A., Montagnani M., Koh K.K., Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113:1888-1904.
79. Knekt P., Isotupa S., Rissanen H., Heliovaara M., Jarvinen R., Hakkinen S., Aromaa A., Reunanen A. Quercetin intake and the incidence of cerebrovascular disease. Eur. J. Clin. Nutr. 2000, 54:415-417.
80. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., Hakulinen T., Aromaa A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76:560-568.
81. Kobori M., Masumoto S., Akimoto Y., Takahashi Y. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res. 2009, 53:859-868.
82. Kobuchi H., Roy S., Sen C.K., Nguyen H.G., Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am. J. Physiol. 1999, 277:C403-411.
83. Kroon P.A., Clifford M.N., Crozier A., Day A.J., Donovan J.L., Manach C., Williamson G. How should we assess the effects of exposure to dietary polyphenols in vitro?. Am. J. Clin. Nutr. 2004, 80:15-21.
84. Kwon O., Eck P., Chen S., Corpe C.P., Lee J.H., Kruhlak M., Levine M. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 2007, 21:366-377.
85. Lee-Hilz Y.Y., Stolaki M., van Berkel W.J., Aarts J.M., Rietjens I.M. Activation of EpRE-mediated gene transcription by quercetin glucuronides depends on their deconjugation. Food Chem. Toxicol. 2008, 46:2128-2134.
86. Li Y.Q., Zhou F.C., Gao F., Bian J.S., Shan F. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J. Agric. Food Chem. 2009, 57:11463-11468.
87. Liang C., Decourcy K., Prater M.R. High-saturated-fat diet induces gestational diabetes and placental vasculopathy in C57BL/6 mice. Metabolism 2009, 59:943-950.
88. Liang C., Oest M.E., Prater M.R. Intrauterine exposure to high saturated fat diet elevates risk of adult-onset chronic diseases in C57BL/6 mice. Birth Defects Res. B Dev. Reprod. Toxicol. 2009, 86:377-384.
89. Lodi F., Jimenez R., Menendez C., Needs P.W., Duarte J., Perez-Vizcaino F. Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. Planta Med. 2008, 74:741-746.
90. Lodi F., Jimenez R., Moreno L., Kroon P.A., Needs P.W., Hughes D.A., Santos-Buelga C., Gonzalez-Paramas A., Cogolludo A., Lopez-Sepulveda R., Duarte J., Perez-Vizcaino F. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 2009, 204:34-39.
91. Loke W.M., Hodgson J.M., Proudfoot J.M., McKinley A.J., Puddey I.B., Croft K.D. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am. J. Clin. Nutr. 2008, 88:1018-1025.
92. Loke W.M., Proudfoot J.M., Hodgson J.M., McKinley A.J., Hime N., Magat M., Stocker R., Croft K.D. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2010, 30:749-757.
93. Lopez-Lopez G., Moreno L., Cogolludo A., Galisteo M., Ibarra M., Duarte J., Lodi F., Tamargo J., Perez-Vizcaino F. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. Mol. Pharmacol. 2004, 65:851-859.
94. Luo H., Jiang B.H., King S.M., Chen Y.C. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr. Cancer 2008, 60:800-809.
95. Lyseng-Williamson K.A., Perry C.M. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs 2003, 63:71-100.
96. Mackraj I., Govender T., Ramesar S. The antihypertensive effects of quercetin in a salt-sensitive model of hypertension. J. Cardiovasc. Pharmacol. 2008, 51:239-245.
97. Machha A., Mustafa M.R. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J. Cardiovasc. Pharmacol. 2005, 46:36-40.
98. Mattagajasingh I., Kim C.S., Naqvi A., Yamamori T., Hoffman T.A., Jung S.B., DeRicco J., Kasuno K., Irani K. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 2007, 104:14855-14860.
99. Mercer L.D., Kelly B.L., Horne M.K., Beart P.M. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem. Pharmacol. 2005, 69:339-345.
100. Miyazaki R., Ichiki T., Hashimoto T., Inanaga K., Imayama I., Sadoshima J., Sunagawa K. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1263-1269.
101. 2+ but requires phosphorylation by Akt at Ser(1179). J. Biol. Chem. 2001, 276:30392-30398.
102. Moon S.K., Cho G.O., Jung S.Y., Gal S.W., Kwon T.K., Lee Y.C., Madamanchi N.R., Kim C.H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 2003, 301:1069-1078.
103. Motoyama K., Koyama H., Moriwaki M., Emura K., Okuyama S., Sato E., Inoue M., Shioi A., Nishizawa Y. Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice. Nutrition 2009, 25:421-427.
104. Munzel T., Hink U., Yigit H., Macharzina R., Harrison D.G., Mulsch A. Role of superoxide dismutase in in vivo and in vitro nitrate tolerance. Br. J. Pharmacol. 1999, 127:1224-1230.
105. Negre-Salvayre A., Salvayre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radic. Biol. Med. 1992, 12:101-106.
106. Nifli A.P., Theodoropoulos P.A., Munier S., Castagnino C., Roussakis E., Katerinopoulos H.E., Vercauteren J., Castanas E. Quercetin exhibits a specific fluorescence in cellular milieu: a valuable tool for the study of its intracellular distribution. J. Agric. Food Chem. 2007, 55:2873-2878.
107. Nomura M., Takahashi T., Nagata N., Tsutsumi K., Kobayashi S., Akiba T., Yokogawa K., Moritani S., Miyamoto K. Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells. Biol. Pharm. Bull. 2008, 31:1403-1409.
108. NuralievIu N., Avezov G.A. The efficacy of quercetin in alloxan diabetes. Eksp. Klin. Farmakol. 1992, 55:42-44.
109. Ota H., Eto M., Ogawa S., Iijima K., Akishita M., Ouchi Y. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J. Atheroscler. Thromb. 2010, 17:431-435.
110. Patil C.S., Singh V.P., Satyanarayan P.S., Jain N.K., Singh A., Kulkarni S.K. Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 2003, 69:59-67.
111. Perez-Vizcaino F., Bishop-Bailley D., Lodi F., Duarte J., Cogolludo A., Moreno L., Bosca L., Mitchell J.A., Warner T.D. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2006, 346:919-925.
112. Perez-Vizcaino F., Duarte J., Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic. Res. 2006, 40:1054-1065.
113. Perez-Vizcaino F., Duarte J., Jimenez R., Santos-Buelga C., Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacol. Rep. 2009, 61:67-75.
114. Perez-Vizcaino F., Ibarra M., Cogolludo A.L., Duarte J., Zaragoza-Arnaez F., Moreno L., Lopez-Lopez G., Tamargo J. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J. Pharmacol. Exp. Ther. 2002, 302:66-72.
115. Picq M., Dubois M., Prigent A.F., Nemoz G., Pacheco H. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds. Biochem. Int. 1989, 18:47-57.
116. Pietsch K., Saul N., Menzel R., Sturzenbaum S.R., Steinberg C.E. Quercetin mediated lifespan extension in Caenorhabditis elegans is modulated by age-1, daf-2, sek-1 and unc-43. Biogerontology 2009, 10:565-578.
117. Pignatelli P., Di Santo S., Buchetti B., Sanguigni V., Brunelli A., Violi F. Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment. FASEB J. 2006, 20:1082-1089.
118. Punithavathi V.R., Prince P.S. Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats. Life Sci. 2010, 86:178-184.
119. + channels. Trends Pharmacol. Sci. 1989, 10:431-435.
120. Reaven G.M., Chang H. Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto rats. Am. J. Hypertens. 1991, 4:34-38.
121. Regazzetti C., Peraldi P., Gremeaux T., Najem-Lendom R., Ben-Sahra I., Cormont M., Bost F., Le Marchand-Brustel Y., Tanti J.F., Giorgetti-Peraldi S. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 2009, 58:95-103.
122. Rivera F., Costa G., Abin A., Urbanavicius J., Arruti C., Casanova G., Dajas F. Reduction of ischemic brain damage and increase of glutathione by a liposomal preparation of quercetin in permanent focal ischemia in rats. Neurotox. Res. 2008, 13:105-114.
123. Rivera L., Moron R., Sanchez M., Zarzuelo A., Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008, 16:2081-2087.
124. Rodbard H.W., Blonde L., Braithwaite S.S., Brett E.M., Cobin R.H., Handelsman Y., Hellman R., Jellinger P.S., Jovanovic L.G., Levy P., Mechanick J.I., Zangeneh F. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr. Pract. 2007, 13(Suppl. 1):1-68.
125. Romero M., Jimenez R., Sanchez M., Lopez-Sepulveda R., Zarzuelo M.J., O'Valle F., Zarzuelo A., Perez-Vizcaino F., Duarte J. Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis 2009, 202:58-67.
126. Romero M., Jimenez R., Hurtado B., Moreno J.M., Rodriguez-Gomez I., Lopez-Sepulveda R., Zarzuelo A., Perez-Vizcaino F., Tamargo J., Vargas F., Duarte J. Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats. Eur. J. Pharmacol. 2010, 627:242-250.
127. Rusznyak S., Szent-Györgyi A. Vitamin P: flavonols as vitamins. Nature 1936, 138:27-29.
128. Sanchez M., Galisteo M., Vera R., Villar I.C., Zarzuelo A., Tamargo J., Perez-Vizcaino F., Duarte J. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J. Hypertens. 2006, 24:75-84.
129. Sanchez M., Lodi F., Vera R., Villar I.C., Cogolludo A., Jimenez R., Moreno L., Romero M., Tamargo J., Perez-Vizcaino F., Duarte J. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta. J. Nutr. 2007, 137:910-915.
130. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
131. Sesti G. Pathophysiology of insulin resistance. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20:665-679.
132. Sharma V., Mishra M., Ghosh S., Tewari R., Basu A., Seth P., Sen E. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res. Bull. 2007, 73:55-63.
133. Shutenko Z., Henry Y., Pinard E., Seylaz J., Potier P., Berthet F., Girard P., Sercombe R. Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochem. Pharmacol. 1999, 57:199-208.
134. Silva B., Oliveira P.J., Dias A., Malva J.O. Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotective against excitotoxic insults. Neurotox. Res. 2008, 13:265-279.
135. Simonyi A., Wang Q., Miller R.L., Yusof M., Shelat P.B., Sun A.Y., Sun G.Y. Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol. Neurobiol. 2005, 31:135-147.
136. Song Y., Manson J.E., Buring J.E., Sesso H.D., Liu S. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J. Am. Coll. Nutr. 2005, 24:376-384.
137. Stewart L.K., Soileau J.L., Ribnicky D., Wang Z.Q., Raskin I., Poulev A., Majewski M., Cefalu W.T., Gettys T.W. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 2008, 57:S39-46.
138. Stoclet J.C., Kleschyov A., Andriambeloson E., Diebolt M., Andriantsitohaina R. Endothelial no release caused by red wine polyphenols. J. Physiol. Pharmacol. 1999, 50:535-540.
139. Strobel P., Allard C., Perez-Acle T., Calderon R., Aldunate R., Leighton F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem. J. 2005, 386:471-478.
140. Stump C.S., Henriksen E.J., Wei Y., Sowers J.R. The metabolic syndrome: role of skeletal muscle metabolism. Ann. Med. 2006, 38:389-402.
141. Suchankova G., Nelson L.E., Gerhart-Hines Z., Kelly M., Gauthier M.S., Saha A.K., Ido Y., Puigserver P., Ruderman N.B. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem. Biophys. Res. Commun. 2009, 378:836-841.
142. Suri S., Liu X.H., Rayment S., Hughes D.A., Kroon P.A., Needs P.W., Taylor M.A., Tribolo S., Wilson V.G. Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery. Br. J. Pharmacol. 2010, 159:566-575.
143. Tauber A.I., Fay J.R., Marletta M.A. Flavonoid inhibition of the human neutrophil NADPH-oxidase. Biochem. Pharmacol. 1984, 33:1367-1369.
144. Taubert D., Berkels R., Klaus W., Roesen R. Nitric oxide formation and corresponding relaxation of porcine coronary arteries induced by plant phenols: essential structural features. J. Cardiovasc. Pharmacol. 2002, 40:701-713.
145. Tribolo S., Lodi F., Connor C., Suri S., Wilson V.G., Taylor M.A., Needs P.W., Kroon P.A., Hughes D.A. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 2008, 197:50-56.
146. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535.
147. Vlachopoulos C., Tsekoura D., Alexopoulos N., Panagiotakos D., Aznaouridis K., Stefanadis C. Type 5 phosphodiesterase inhibition by sildenafil abrogates acute smoking-induced endothelial dysfunction. Am. J. Hypertens. 2004, 17:1040-1044.
148. Wan L.L., Xia J., Ye D., Liu J., Chen J., Wang G. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit. Cardiovasc. Ther. 2009, 27:28-33.
149. Wiczkowski W., Romaszko J., Bucinski A., Szawara-Nowak D., Honke J., Zielinski H., Piskula M.K. Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. J. Nutr. 2008, 138:885-888.
150. Widlansky M.E., Gokce N., Keaney J.F., Vita J.A. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 2003, 42:1149-1160.
151. Winterbone M.S., Tribolo S., Needs P.W., Kroon P.A., Hughes D.A. Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009, 202:431-438.
152. Wright B., Moraes L.A., Kemp C.F., Mullen W., Crozier A., Lovegrove J.A., Gibbins J.M. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Br. J. Pharmacol. 2010, 159:1312-1325.
153. Yamamoto Y., Oue E. Antihypertensive effect of quercetin in rats fed with a high-fat high-sucrose diet. Biosci. Biotechnol. Biochem. 2006, 70:933-939.
154. Yang J.Y., Della-Fera M.A., Rayalam S., Ambati S., Hartzell D.L., Park H.J., Baile C.A. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 2008, 82:1032-1039.
155. Yochum L., Kushi L.H., Meyer K., Folsom A.R. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol. 1999, 149:943-949.
156. Yoshizumi M., Tsuchiya K., Suzaki Y., Kirima K., Kyaw M., Moon J.H., Terao J., Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem. Biophys. Res. Commun. 2002, 293:1458-1465.
157. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., Shulman G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 2002, 277:50230-50236.
158. Zbarsky V., Datla K.P., Parkar S., Rai D.K., Aruoma O.I., Dexter D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. 2005, 39:1119-1125.
159. Zhao X., Gu Z., Attele A.S., Yuan C.S. Effects of quercetin on the release of endothelin, prostacyclin and tissue plasminogen activator from human endothelial cells in culture. J. Ethnopharmacol. 1999, 67:279-285.